APA (7th ed.) Citation

del Corral-Morales, J., Ayala-de Miguel, C., Quintana-Cortés, L., González-Santiago, S., Fuentes-Pradera, J., & Ayala-de Miguel, P. (2026). Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer. Cancers, 18(10), 1538. https://doi.org/10.3390/cancers18101538

Chicago Style (17th ed.) Citation

del Corral-Morales, José, Carlos Ayala-de Miguel, Laura Quintana-Cortés, Santiago González-Santiago, José Fuentes-Pradera, and Pablo Ayala-de Miguel. "Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer." Cancers 18, no. 10 (2026): 1538. https://doi.org/10.3390/cancers18101538.

MLA (9th ed.) Citation

del Corral-Morales, José, et al. "Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer." Cancers, vol. 18, no. 10, 2026, p. 1538, https://doi.org/10.3390/cancers18101538.